ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus
Completed · Phase 4
Conditions studied: Diabetes Mellitus Type 2
In brief
The purpose of this study is to evaluate whether a combination of pharmacist-delivered patient engagement techniques improves disease control and medication adherence among patients with poorly-controlled diabetes compared with usual care. These engagement techniques include shared decision-making and brief negotiated interviewing and are delivered telephonically.
Key facts
- Study ID
- NCT02910089
- Run by
- AstraZeneca
- People needed
- 1400
- Starts
- 2016-10-20
- Expected to finish
- 2017-12-20
- Last updated by the study team
- 2019-09-17
Who can join
Age: 18 and older, up to 130. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.